Photochemotherapy for psoriasis remission times. Psoralens and UV-A and combined photochemotherapy with anthralin
- 1 December 1979
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 4 (4) , 477-483
- https://doi.org/10.1111/j.1365-2230.1979.tb01644.x
Abstract
Summary: Oral methoxsalen and long-wave ultraviolet light (PUVA) was evaluated in 187 psoriatics, with emphasis on remission and recurrence after therapy. The mean number of years psoriasis had been present was 18.3, the mean psoriatic involvement 34.8% the dose at the time of maximum clearance was 11.8 J/cm2, and the mean number of treatments to achieve maximum clearance was 175. Complete clearance was achieved in sixty-one patients and in this group the average number of treatments to achieve maximum clearance was 16.8, the initial remission times ranged from 4 to 64 weeks, with an average of 21.6 weeks. In patients subsequently retreated, the remission time was only 12.4 weeks (57%), but the mean number of treatments to achieve maximum clearance was reduced (11.4) and patients responded more easily to treatment. Sixteen patients were treated in addition to PUVA, with anthralin in Lassars' paste with clearing achieved between six and fifteen treatments, a mean of 9.5.Combinations of PUVA with other forms of psoriatic treatment may also help to reduce the cumulative PUVA exposures.This publication has 11 references indexed in Scilit:
- Relapse rate of psoriasis worsened by adding steroids to a dithranol regime*British Journal of Dermatology, 1976
- Photochemotherapy for psoriasis with orally administered methoxsalenArchives of Dermatology, 1976
- Photochemotherapy of Psoriasis with Oral Methoxsalen and Longwave Ultraviolet LightNew England Journal of Medicine, 1974
- Photosensitization of the Eye by 8-methoxypsoralen**From the Departments of Dermatology and Pathology, Baylor College of Medicine, Houston, Texas.Journal of Investigative Dermatology, 1969
- DITHRANOL PASTE FOR PSORIASIS.British Journal of Dermatology, 1966
- Erythema and Tumor Formation in Methoxsalen-Treated Mice Exposed to Fluorescent LightArchives of Dermatology, 1960
- Photosensitization of the Eye with MethoxsalenArchives of Ophthalmology (1950), 1960
- Part IV: Basic Considerations of the Psoralens: Clinical and Laboratory Tolerance Studies in Volunteers Given Oral MethoxsalenJournal of Investigative Dermatology, 1959
- The Wave Length Effect Upon Erythemal and Carcinogenic Response in Psoralen Treated Mice11From the Department of Biochemistry, The University of Texas M.D. Anderson Hospital and Tumor Institute and the Departments of Biochemistry and Dermatology, Baylor University College of Medicine, Houston, Texas. Supported by grants from the Robert A. Welch Foundation, Humble Oil and Refining Company and the National Cancer Institute (NCI 2620), U. S. Department of Health, Education and Welfare.Journal of Investigative Dermatology, 1958
- The Approach to PsoriasisBMJ, 1953